What is the P/E ratio of Anbio Biotechnology (NNNN)?

The trailing price-to-earnings (P/E) ratio of Anbio Biotechnology is 229.4.

What is the market capitalization of Anbio Biotechnology?

Anbio Biotechnology (NNNN) has a market capitalization of approximately 1,251,338,112 USD.

Where can I buy NNNN in Canada?

NNNN can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

NNNN

Anbio Biotechnology

Anbio Biotechnology (NNNN) is a Germany company in the healthcare sector, listed on NASDAQ. Market capitalization of 1.3 billion USD (small-cap).

Details

Price28.51 USD

Market cap1.25 G USD

Payout ratio0.00%

ROE27.05%

SectorHealthcare

Websiteanbiobiotechnology.com

Updated 2h ago

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.